MarketPeel
Insider Trading Intelligence
CG

Charles D. II Goodwin

APYX
CHIEF EXECUTIVE OFFICER · APYX MEDICAL CORP · CIK 0001726988
FILING MIX · LIFETIME100%/0%
BUYS
12
SELLS
0
TOTAL VALUE
$241.8K
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
213,948
AVG SELL PX
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Charles D. II Goodwin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+26.48%+0.14%+26.34%+22.73%
14d4+100.00%+39.79%+3.33%+36.46%+19.09%
30d4+50.00%+18.16%-0.49%+18.65%+14.78%
60d4+50.00%+14.98%+3.25%+11.73%+9.72%
90d4+50.00%-0.52%+7.07%-7.58%-14.96%
180d4+25.00%-3.74%+10.63%-14.37%-36.04%
1y4+25.00%+34.82%+27.42%+7.40%-35.83%
2y4+50.00%+6.79%+46.36%-39.56%-78.19%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
APYX · 213,948 shares · as of Jun 11, 2026
060,750121,500182,250243,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 12 buys / 0 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
213,948213,948Jun 11, 2026Jun 15, 2026View →
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
193,000193,000May 15, 2025May 19, 2025View →
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
50,00050,000Jan 15, 2025Jan 17, 2025View →
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
243,0000Jan 10, 2024Jan 11, 2024View →
APYX
APYX MEDICAL CORP
PURCHASE
Chief Executive Officer
50,000$1.57$78.5K90,000Nov 14, 2023Nov 15, 2023View →
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
243,000243,000Jan 11, 2023Jan 13, 2023View →
APYX
APYX MEDICAL CORP
PURCHASE
Chief Executive Officer
9,750$5.97$58.2K40,000Aug 29, 2022Aug 31, 2022View →
APYX
APYX MEDICAL CORP
PURCHASE
Chief Executive Officer
2,000$5.93$11.9K30,250Aug 29, 2022Aug 31, 2022View →
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
243,000243,000Jan 19, 2022Jan 30, 2022View →
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
121,500121,500Jan 29, 2021Feb 8, 2021View →
APYX
APYX MEDICAL CORP
PURCHASE
Chief Executive Officer
28,250$3.30$93.2K28,250May 13, 2020May 14, 2020View →
APYX
APYX MEDICAL CORP
PURCHASEGRANT
Stock grant
243,000243,000Jan 15, 2020Jan 15, 2020View →
Other insiders · APYX
Loading peer insiders…
About this filer
CIK 0001726988
ROLE
Chief Executive Officer
PRIMARY
APYX
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001726988DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback